Israel - English - Ministry of Health

tradis gat ltd - citric acid anhydrous; light magnesium oxide; sodium picosulfate - powder for solution - citric acid anhydrous 10.97 g; light magnesium oxide 3.5 g; sodium picosulfate 10 mg - sodium picosulfate, combinations - for bowel cleansing prior to any diagnostic procedures requiring a clean bowel e.g. colonoscopy or x-ray examination.

Malta - English - Medicines Authority

casen recordati, s.l. autovia de logrono, km 13,300, 50180 utebo, zaragoza, spain - sodium picosulfate, magnesium oxide, light, citric acid, anhydrous - powder for oral solution - sodium picosulfate 10 mg magnesium oxide, light 3.5 g citric acid anhydrous 10.97 g - drugs for constipation

Ireland - English - HPRA (Health Products Regulatory Authority)

casen-recordati s.l. - sodium picosulfate; light magnesium oxide; citric acid anhydrous - powder for oral solution in sachet - 10,3.5,10.97 gram(s) - contact laxatives; sodium picosulfate, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

casen-recordati s.l. - sodium picosulfate; magnesium oxide, light ; citric acid - oral solution - sodium picosulfate, combinations

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

casen recordati s.l. - sodium picosulfate; magnesium oxide light; citric acid monohydrate - powder - 10mg ; 3.5gram ; 12gram

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - citric acid 12 g;  ; light magnesium oxide 3.5 g; sodium picosulfate 10mg - powder for oral solution - active: citric acid 12 g   light magnesium oxide 3.5 g sodium picosulfate 10mg excipient: orange flavour 655280 potassium bicarbonate saccharin sodium - for clearance of the bowel prior to examination by radiography, endoscopy or surgery.

Singapore - English - HSA (Health Sciences Authority)

ferring pharmaceuticals private limited - citric acid, anhydrous; magnesium oxide, light; sodium picosulfate - powder, for solution - 12 g - citric acid, anhydrous 12 g; magnesium oxide, light 3.5 g; sodium picosulfate 10 mg

United States - English - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - sodium picosulfate (unii: lr57574hn8) (deacetylbisacodyl - unii:r09078e41y), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium picosulfate 10 mg in 160 ml - clenpiq is indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 9 years of age and older. clenpiq is contraindicated in the following conditions: - patients with severe renal impairment (creatinine clearance less than 30 ml/minute), which may result in accumulation of magnesium [see warnings and precautions (5.3)]. - gastrointestinal obstruction or ileus [see warnings and precautions (5.6)]. - bowel perforation [see warnings and precautions (5.6)]. - toxic colitis or toxic megacolon. - gastric retention. - hypersensitivity to any of the ingredients in clenpiq [see adverse reactions (6.2)]. risk summary there are no data with clenpiq use in pregnant women to determine a drug-associated risk of adverse developmental outcomes. in animal reproduction studies, no adverse developmental effects were observed in pregnant rats when sodium picosulfate, magnesium oxide, and anhydrous citric acid were administered orally at doses 1.2 times the recommended human dose based

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - citric acid, quantity: 12 g; sodium picosulfate, quantity: 10 mg; light magnesium oxide, quantity: 3.5 g - solution, powder for - excipient ingredients: potassium bicarbonate; saccharin sodium; purified water; flavour - to clean the bowel prior to x-ray examination, endoscopy or surgery.

United States - English - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - sodium picosulfate (unii: lr57574hn8) (deacetylbisacodyl - unii:r09078e41y), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium picosulfate 10 mg in 16.1 g - prepopik® is indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 9 years of age and older. prepopik is contraindicated in the following conditions: - patients with severe renal impairment (creatinine clearance less than 30 ml/minute) which may result in accumulation of magnesium [see warnings and precautions (5.4)] - gastrointestinal obstruction or ileus [see warnings and precautions (5.6)] - bowel perforation [see warnings and precautions (5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any of the ingredients in prepopik [see adverse reactions (6.2)] risk summary there are no data with prepopik use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in an animal reproduction study, no adverse developmental effects were observed in pregnant rats when sodium picosulfate, magnesium oxide, and anhydrous citric acid were administered orally at doses 1